Joy Laoun
News Editor, Vestbee
The Series B round was led by Headline, with support from Creandum, HTGF, and xdeck.
The funds are provided by Mabylon’s existing private investors, with the major investment coming from former management and board members of Roche.
The pre-seed round was led by Twin Path Ventures, with participation from Atlas AI^VB Fund I, XTX Ventures, and SFC Capital.
The fund is backed by Aarhus University Research Foundation, HEARTLAND, Norlys, and Salling Group.
The Series B round was led by Headline, with support from Creandum, HTGF, and xdeck.
Elina Halatcheva from BrightCap Ventures told Vestbee about the fund’s strategy and investment approach.